Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous magnesium versus lidocaine versus placebo for postoperative outcomes after laparoscopic cholecystectomy
PACTR202509503569442Phase 2Recruiting
- Sponsor
- LR12DN01
- Start
- Jul 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in cholelithiasis comparing Lidocaine Group, Magnesium Group and Placebo Group (3 arms). Primary endpoint: Time to recovery of intestinal transit. Started Jul 2025; status: recruiting.
02
Drugs
lidocainemagnesium
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on PACTR202509503569442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509503569442.